Electromed, Inc. (ELMD) Stock Score, Valuation & Financial Research

Electromed, Inc. is in the Healthcare sector and Medical - Devices industry. It is reviewed using Wall Street Score's company-strength, valuation, growth and financial-health framework. The current Wall Street Score is 59/100.

Quick answer for ELMD

Electromed, Inc. currently has a Wall Street Score of 59/100. The stored market price is $26.15. Its financial score is 37/100. Its valuation score is 93/100. These figures are a research snapshot, not a buy or sell recommendation.

What Electromed, Inc. does

Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy, muscular dystrophies, amyotrophic lateral sclerosis, and post-surgical complications; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians

ELMD financial snapshot

Wall Street Score:
59/100
Current price:
$26.15
Market capitalization:
$216.5M
Revenue:
$73.8M
Net income:
$11.3M
Free cash flow:
$8.4M
Cash:
$20.4M
Total debt:
$133K
EPS:
1.37
P/E ratio:
19.1x
Financial score:
37/100
Valuation score:
93/100
Revenue score:
27/100

What stands out

  • Reported year-over-year revenue growth is +0.0%.
  • Free cash flow is $8.4M, showing positive cash generation.
  • The balance sheet shows $20.4M of cash versus $133K of total debt, leaving more cash than debt.

What the numbers mean

Its current valuation score is 93/100, which Wall Street Score classifies as strong within the model's valuation framework.

The financial score is 37/100. This is a starting point for reviewing liquidity, leverage and cash-flow strength rather than a stand-alone recommendation.

A strong company and an attractive stock price are not always the same thing. Revenue, earnings, free cash flow, debt, management quality, competitive advantage and valuation should be considered together. Wall Street Score organizes these inputs into a consistent research framework so investors can identify what deserves deeper review.

Data freshness: Financial data last refreshed 2026-09-07.

How to research ELMD

Start by understanding how the company makes money. Then compare revenue and earnings trends, cash generation, debt, liquidity and valuation. Review the company's latest filings and earnings reports before acting on any score or model estimate.

Learn how to analyze a stock · Read the Wall Street Score methodology · Browse other stocks

Data may change as company filings and market prices update. Educational research only; not a buy or sell recommendation.